CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2659/ihc_cell_selected_60x60.jpg) | ![](/images/2659/6600_B_9_3_rna_selected_60x60.jpg) | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images/8928/if_selected_60x60.jpg) | | ![](/images/2624/6433_A_9_8_rna_selected_60x60.jpg) | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16110/36118_A_9_1_rna_selected_60x60.jpg) | Group enriched |
FCRLA | Fc receptor-like A | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16545/35769_B_7_6_rna_selected_60x60.jpg) | Group enriched |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2505/6522_A_7_1_rna_selected_60x60.jpg) | Group enriched |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4906/19765_B_7_4_rna_selected_60x60.jpg) | Group enriched |
HLA-DOB | Major histocompatibility complex, class II, DO beta | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13846/32452_A_9_7_rna_selected_60x60.jpg) | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | ![](/images/8380/if_selected_60x60.jpg) | ![](/images/3246/ihc_cell_selected_60x60.jpg) | ![](/images/8380/19870_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/685/1469_B_1_5_rna_selected_60x60.jpg) | Group enriched |
ITGAM | Integrin, alpha M (complement component 3 receptor 3 subunit) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2274/7204_B_8_2_rna_selected_60x60.jpg) | Group enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48884/109189_B_8_4_rna_selected_60x60.jpg) | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2144/ihc_cell_selected_60x60.jpg) | ![](/images/2144/5972_A_7_7_rna_selected_60x60.jpg) | Group enriched |
TREM1 | Triggering receptor expressed on myeloid cells 1 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5563/15821_A_6_1_rna_selected_60x60.jpg) | Group enriched |
CLEC4A | C-type lectin domain family 4, member A | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7842/21426_B_5_6_rna_selected_60x60.jpg) | Tissue enhanced |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/42455/if_selected_60x60.jpg) | ![](/images/2491/ihc_cell_selected_60x60.jpg) | ![](/images/2491/6134_B_1_3_rna_selected_60x60.jpg) | Tissue enhanced |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65474/146784_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32017/139602_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
FYB | FYN binding protein | | | ![](/images/26796/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25336/89134_A_3_4_rna_selected_60x60.jpg) | Tissue enhanced |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | ![](/images/49864/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49864/127576_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
GBP5 | Guanylate binding protein 5 | | | ![](/images/28656/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28656/60702_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
IL4I1 | Interleukin 4 induced 1 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45598/102703_A_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins
| | ![](/images/4723/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4458/14041_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
MARCO | Macrophage receptor with collagenous structure | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/8847/ihc_cell_selected_60x60.jpg) | ![](/images/63793/143123_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC14 | Sialic acid binding Ig-like lectin 14 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14377/33569_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
SIGLEC5 | Sialic acid binding Ig-like lectin 5 | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24900/57350_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
TNFAIP6 | Tumor necrosis factor, alpha-induced protein 6 | Plasma proteins Predicted secreted proteins
| | ![](/images/7896/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/50884/133682_A_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
VCAN | Versican | Disease related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/4726/12822_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
VIP | Vasoactive intestinal peptide | Cancer-related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17324/44725_A_6_8_rna_selected_60x60.jpg) | Tissue enhanced |